Heligenics technology is used to transform genetic diagnostics and discover new Biologics for major diseases.
Heligenics has raised $2.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2025.
Heligenics is headquartered in Las Vegas, United States.
Heligenics technology is used to transform genetic diagnostics and discover new Biologics for major diseases.
Heligenics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Heligenics — Funding & Investors." VCBacked, January 8, 2025, https://www.vcbacked.co/company/heligenics. Accessed September 12, 2026.
VCBacked. (2025). Heligenics — Funding & Investors. Retrieved September 12, 2026, from https://www.vcbacked.co/company/heligenics
{{cite web |title=Heligenics — Funding & Investors |url=https://www.vcbacked.co/company/heligenics |website=VCBacked |access-date=September 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated